This webinar program will focus on the theme of innovation and scientific engagement in Medical Communications, providing a detailed example of how a hackathon event is a valuable approach to enhance idea generation for a defined challenge and presents the opportunity to develop innovative “out-of-the box” solutions as a primary outcome of the event.
The objectives of this webinar are to present alternate views on a particular issue that is of concern to the Medical Affairs community while also attempting to resolve the issue.
In today’s episode, we’re talking with Joseph Zabinski, PhD, Senior Director, AI & Personalized Medicine at OM1 about Artificial Intelligence — specifically about how AI can accelerate diagnosis and treatment.
In this episode, we’re talking about publications impact with Mike Taylor, Head of Data Insights and Grainne Farrell, Manager Corporate Life Science, Central Europe, both at Digital Science.
A panel of experts will discuss what they have learnt from the last 2 years to take forward to future congress offerings, while also exploring what HCPs want when joining congresses both virtually or face-to-face.
In this episode, experts discuss patient-centricity strategies and actions that make patient-first thinking the heart of your organization’s plans.
This webinar will discuss how MA colleagues are best positioned to explore the fusion of PE and PED in the post-launch phase, including generation and use of RWD and RW evidence, and will share guidance and information on several industry-supported resources, to enable MA colleagues to implement PE and evidence strategies in their function.
In this episode, experts discuss patient-centricity strategies and actions that make patient-first thinking the heart of your organization’s plans.
The goal of this webinar is to enable MedAffairs Organizations and their MSLs to better align and deliver scientific exchange per new KOL expectations, and provide more value through agile & personalized content assembly capability that can empower MSLs.
In this e-book, learn how medical affairs teams can use technology to address diversity issues in the drug development life cycle.